Faye Feller, M.D.
About Faye Feller, M.D.
Faye Feller Executive Vice President at Geron
Faye Feller, M.D., serves as the Executive Vice President and Chief Medical Officer at Geron. In this role, Dr. Feller is responsible for overseeing the company's medical and clinical strategies. Her leadership extends to steering efforts in the development and potential commercialization of innovative therapies.
Faye Feller Chief Medical Officer Responsibilities
As the Chief Medical Officer, Dr. Faye Feller plays a critical role in guiding the medical and clinical direction of Geron's projects. One of her primary focuses is on the development and potential commercialization of imetelstat, a groundbreaking therapy that has shown promise in treating hematologic malignancies. Her responsibilities encompass ensuring that clinical programs align with regulatory standards and company objectives.
Faye Feller M.D. Education
Dr. Faye Feller holds a Doctor of Medicine (M.D.) degree. Her medical education underpins her extensive knowledge and expertise, which she brings to her executive role at Geron. Her academic background provides a strong foundation for her work in medical research and clinical development.
Faye Feller's Expertise in Hematologic Malignancies
Dr. Faye Feller possesses significant regulatory experience in hematologic malignancies. Her expertise is crucial in navigating the complex landscape of regulatory requirements, particularly in the development of therapies aimed at treating blood cancers. Her role involves ensuring that these therapies meet all necessary regulatory standards for approval and commercialization.
Faye Feller's Experience in Oligonucleotide Manufacturing
Dr. Feller has specialized expertise in the manufacturing of oligonucleotides. This experience is essential for the development of innovative therapies such as imetelstat. Her knowledge in this specialized area ensures that Geron's manufacturing processes meet the highest standards of quality and efficacy.